OPEN END TURBO BEAR OPTIONSSCHEIN - ASTRAZENECA | Real-time BOERSE MUENCHEN 07:16:24 27/06/2024 pm IST | ||
| 2.36 EUR | +3.06% |
|
| Current month | -12.60% | ||
| 1 month | -8.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 2.36 | +3.06% |
| 26/24/26 | 2.29 | +0.44% |
| 25/24/25 | 2.28 | -2.98% |
| 24/24/24 | 2.35 | +0.86% |
| 21/24/21 | 2.33 | -4.90% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 07:16 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HC62GD |
| ISIN | DE000HC62GD7 |
| Date issued | 14/04/2023 |
| Strike | 14,443 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.97 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.93 € |
|---|---|
| Lowest since issue | 2.14 € |
| Spread | 0.01 € |
| Spread % | 0.43% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
158.5
USD
Average target price
174.4
USD
Spread / Average Target
+10.04%
- Stock Market
- Certificates
- Certificat
